Selank for anxiety: what TikTok gets wrong about this peptide

What did @sadiegaw actually say?

After nearly a week on selank, @sadiegaw describes it as an "anti-anxiety and anti-stress peptide" that has helped her feel more relaxed and focused without numbing her thoughts entirely. She's refreshingly honest: she still overthought during a social weekend. She's not claiming a cure. She calls it a "great addition" to her peptide stack, notes improved focus and mood, and promises more updates. She also flags upfront that this is "for research purposes only and not medical advice." That disclaimer matters, and we'll get to why.

The headline claim here is that selank, taken over roughly a week, produced a noticeable but partial reduction in anxious overthinking, along with better focus and a more positive baseline mood on a Monday morning. Those are subjective, self-reported outcomes from a single person. That doesn't make them meaningless, but it does set the evidentiary ceiling pretty low.

Does the science back this up?

Partially, yes. The Russian research on selank is real, but it comes with major caveats. Selank is a synthetic heptapeptide derived from tuftsin, originally developed at the Institute of Molecular Genetics in Moscow. The anxiolytic effects @sadiegaw describes are at least biologically plausible based on what we know about its mechanism.

Selank appears to influence GABA-A receptor modulation and to upregulate brain-derived neurotrophic factor (BDNF) expression, which is associated with mood regulation. Semenova et al. (2010, CNS Drug Reviews) found anxiolytic effects in animal models comparable to benzodiazepines without sedation or dependence. Zozulya et al. (2001, Bulletin of Experimental Biology and Medicine) showed selank stabilized enkephalin levels in rodents, which may contribute to stress buffering.

The problem is that nearly all peer-reviewed selank research is preclinical, conducted in Russia, or involves very small human samples. There are no large, randomized, placebo-controlled trials published in major Western journals. The human evidence is thin enough that drawing firm conclusions about efficacy in people is premature. Her experience is plausible. It is not proven.

What did they get wrong (or right)?

She got more right than most peptide TikTok. Credit where it's due: calling out that selank "isn't a magic potion" and acknowledging she still experienced overthinking is honest and responsible. Most peptide influencers don't do that.

What she got wrong, or at least undersold, is the regulatory and safety context. Selank is not FDA-approved for any indication. It is not a licensed medication in the United States. Calling it an "anti-anxiety peptide" as a category descriptor is technically a disease claim, the kind regulators notice. The peptide has no approved therapeutic use in the US, which means anyone sourcing it is getting it from compounding pharmacies or research chemical suppliers, two very different risk profiles.

She also doesn't mention peptide degradation, bioavailability, or sourcing quality. Intranasal selank, which is the most common route in research, has different absorption characteristics than subcutaneous injection. Without knowing her formulation, dose, or source, her results are nearly impossible to contextualize. The one-week timeframe is also short for drawing conclusions about sustained anxiolytic effects.

What should you actually know?

If you're considering selank for anxiety, the honest answer is that we don't have enough human data to tell you it works at a population level. The mechanism is plausible. Some small studies suggest real effects. But "plausible" and "proven" are not the same thing, and anxiety is a serious condition that responds to established treatments like CBT, SSRIs, and SNRIs with decades of controlled trial data behind them.

Selank is not scheduled in the US, but it also isn't approved. Sourcing matters enormously. Research chemical suppliers are unregulated, and compounded peptides vary in purity and concentration. The peptide is also relatively short-acting, with a half-life measured in minutes without stabilizers, which affects how and when it should be taken.

@sadiegaw's experience is her experience. N=1 anecdotes are where hypotheses start, not where they end. If you're managing real anxiety, talk to a licensed provider before adding any peptide to your routine, especially one with this limited a human evidence base.